Isthmus Partners, LLC Exact Sciences Corp Transaction History

Isthmus Partners, LLC

  • $815 Million
  • Q3 2024

A detailed history of Isthmus Partners, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Isthmus Partners, LLC holds 11,227 shares of EXAS stock, worth $648,920. This represents 0.09% of its overall portfolio holdings.

Number of Shares
11,227
Previous 11,227 -0.0%
Holding current value
$648,920
Previous $474,000 61.18%
% of portfolio
0.09%
Previous 0.06%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024
SELL
$41.33 - $74.26 $41,330 - $74,260
-1,000 Reduced 8.18%
11,227 $474,000
Q1 2024

May 07, 2024
SELL
$56.27 - $73.77 $112,877 - $147,982
-2,006 Reduced 14.09%
12,227 $844,000
Q3 2023

Nov 14, 2023
BUY
$65.94 - $99.04 $133,660 - $200,754
2,027 Added 16.61%
14,233 $970,000
Q2 2023

Aug 03, 2023
BUY
$62.68 - $95.05 $376 - $570
6 Added 0.05%
12,206 $1.15 Million
Q1 2023

May 10, 2023
BUY
$47.19 - $70.77 $47,190 - $70,770
1,000 Added 8.93%
12,200 $827,000
Q3 2022

Nov 14, 2022
BUY
$31.97 - $49.37 $51,631 - $79,732
1,615 Added 16.85%
11,200 $364,000
Q2 2022

Aug 08, 2022
BUY
$35.61 - $76.23 $35,610 - $76,230
1,000 Added 11.65%
9,585 $378,000
Q4 2021

Jan 25, 2022
BUY
$72.5 - $100.68 $145,000 - $201,360
2,000 Added 30.37%
8,585 $668,000
Q2 2019

Aug 09, 2019
SELL
$89.51 - $118.04 $2.19 Million - $2.88 Million
-24,421 Reduced 78.76%
6,585 $777,000
Q1 2019

Apr 19, 2019
BUY
$61.98 - $96.5 $1.51 Million - $2.36 Million
24,421 Added 370.86%
31,006 $1.79 Million
Q2 2018

Aug 02, 2018
SELL
$37.84 - $69.96 $75,680 - $139,920
-2,000 Reduced 23.3%
6,585 $394,000
Q1 2018

May 11, 2018
SELL
$39.82 - $57.53 $199,100 - $287,650
-5,000 Reduced 36.81%
8,585 $346,000
Q4 2017

Feb 05, 2018
SELL
$46.49 - $60.51 $114,597 - $149,157
-2,465 Reduced 15.36%
13,585 $714,000
Q3 2017

Nov 02, 2017
BUY
$37.05 - $47.12 $594,652 - $756,276
16,050
16,050 $756,000

Others Institutions Holding EXAS

# of Institutions
676
Shares Held
162M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Isthmus Partners, LLC Portfolio

Follow Isthmus Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Isthmus Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Isthmus Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email